FDA Approves First And Only IV Treatment For Migraine Prevention  Overall, in the randomized double blind studies, patients’ mean migraine frequency changed from the baseline, of around 8.6 migraines per month, to 50 to 75 percent reduction in migraines over the course of several months. 